Chlophedianol Hydrochloride

CHEMBL1200972 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
326.3 g/mol
LogP
Phase
4

The hydrochloride salt of chlophedianol is used as a cough suppressant in over-the-counter combination formulations. It shares the centrally acting antitussive mechanism of the parent compound. It is sometimes combined with antihistamines or decongestants for broader cold and allergy symptom relief.

Moleküler Ağırlık

326,3000 g/mol

TPSA

23,50 Ų

Etki Mekanizması

Competitively blocks histamine H1 receptors on effector cells, preventing histamine-mediated vasodilation, increased vascular permeability, bronchoconstriction, and pruritus. First-generation agents also cross the blood-brain barrier, causing sedation.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mekanizma

Competitively blocks histamine H1 receptors on effector cells, preventing histamine-mediated vasodilation, increased vascular permeability, bronchoconstriction, and pruritus. First-generation agents also cross the blood-brain barrier, causing sedation.

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CN(C)CCC(O)(c1ccccc1)c1ccccc1Cl.Cl

InChI

InChI=1S/C17H20ClNO.ClH/c1-19(2)13-12-17(20,14-8-4-3-5-9-14)15-10-6-7-11-16(15)18;/h3-11,20H,12-13H2,1-2H3;1H

Molecular Formula

C17H21Cl2NO

HBD / HBA

2 / 2

Döndürülebilir Bağlar

5

Ağır Atomlar

21

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

The hydrochloride salt of chlophedianol is used as a cough suppressant in over-the-counter combination formulations. It shares the centrally acting antitussive mechanism of the parent compound. It is sometimes combined with antihistamines or decongestants for broader cold and allergy symptom relief.

Competitively blocks histamine H1 receptors on effector cells, preventing histamine-mediated vasodilation, increased vascular permeability, bronchoconstriction, and pruritus. First-generation agents also cross the blood-brain barrier, causing sedation.

Yes, Chlophedianol Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200972. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 83813. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.